Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFAGX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $115,982
Award facts
- Contract value 100% obligated
- $115,981.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $115,981.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Cosentyx (secukinumab) 300 mg pens in 2 mL formulation, with an ultimate completion date of September 8, 2025. This competitively awarded contract, which carries no set-aside designation, is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle valued through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical and medical supply deliveries to military and veteran healthcare systems. The company's DLA IDC serves as a global pharmaceutical support mechanism enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Cosentyx, a biologic immunosuppressant medication, reflects AmerisourceBergen's capability to deliver specialized pharmaceutical products to federal customers through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FFAGX?
SPE2DB25FFAGX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FFAGX worth?
The government has obligated $115,982 on SPE2DB25FFAGX.
Is contract SPE2DB25FFAGX an order under another contract?
Yes. SPE2DB25FFAGX is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FFAGX competed?
The extent of competition for SPE2DB25FFAGX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award